ArticleThe Journal of international medical research2016

Poor response to platinum-based chemotherapy is associated with KRAS mutation and concomitant low expression of BRAC1 and TYMS in NSCLC.

Hongxuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.